These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16522150)

  • 81. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 83. The EU REACH system: blessing in disguise or wolf in wolf's clothing?
    Bhogal N
    Altern Lab Anim; 2005 Apr; 33(2):81-2. PubMed ID: 16180983
    [No Abstract]   [Full Text] [Related]  

  • 84. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods.
    Genschow E; Spielmann H; Scholz G; Seiler A; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K
    Altern Lab Anim; 2002; 30(2):151-76. PubMed ID: 11971753
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. The report and recommendations of ECVAM workshop 61.
    Metz B; Brunel F; Chamberlin C; van der Gun J; Halder M; Jiskoot W; Kersten G; van Opstal O; Petersen JW; Ravetkar SD; Redhead K; Schwanig M; Wilhelmsen ES; Vann WF; Hendriksen C
    Altern Lab Anim; 2007 Jun; 35(3):323-31. PubMed ID: 17650951
    [No Abstract]   [Full Text] [Related]  

  • 86. Reply to: Bayesian network integrated testing strategy and beyond.
    Jaworska J
    ALTEX; 2013; 30(3):391. PubMed ID: 23861082
    [No Abstract]   [Full Text] [Related]  

  • 87. Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.
    Prieto P; Cole T; Curren R; Gibson RM; Liebsch M; Raabe H; Tuomainen AM; Whelan M; Kinsner-Ovaskainen A
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):344-65. PubMed ID: 23246604
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Future improvements: replacement in vitro methods.
    Balls M
    ILAR J; 2002; 43 Suppl():S69-73. PubMed ID: 12388855
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Three-dimensional cell cultures in toxicology.
    Pampaloni F; Stelzer E
    Biotechnol Genet Eng Rev; 2010; 26():117-38. PubMed ID: 21415878
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Metabolic activity in primary cultures of fish hepatocytes.
    Segner H; Cravedi JP
    Altern Lab Anim; 2001; 29(3):251-7. PubMed ID: 11387022
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Invertebrates in testing of environmental chemicals: are they alternatives?
    Lagadic L; Caquet T
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):593-611. PubMed ID: 9599707
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
    [No Abstract]   [Full Text] [Related]  

  • 93. Possibilities for a new approach to chemicals risk assessment -- the report of a FRAME workshop.
    Combes R; Balls M; Illing P; Bhogal N; Dale J; Duvé G; Feron V; Grindon C; Gülden M; Loizou G; Priston R; Westmoreland C;
    Altern Lab Anim; 2006 Dec; 34(6):621-49. PubMed ID: 17266394
    [No Abstract]   [Full Text] [Related]  

  • 94. Intelligent testing strategies for chemicals testing -- a case of more haste, less speed?
    Combes R; Balls M
    Altern Lab Anim; 2005 Jun; 33(3):289-97. PubMed ID: 16180981
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.
    Wilk-Zasadna I; Bernasconi C; Pelkonen O; Coecke S
    Toxicology; 2015 Jun; 332():8-19. PubMed ID: 25456264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
    Zuang V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):93-101. PubMed ID: 18333717
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The establishment of ECVAM and its progress since 1993.
    Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():5-11. PubMed ID: 12513646
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.